Pharmacogenomics Reporter | December 5, 2007

Search the GenomeWeb Intelligence Network

Advanced Search

Pharmacogenomics Reporter
GenomeWeb News Premium Content
Existing subscribers login here.
New to Pharmacogenomics Reporter? For a trial subscription click here.

Volume 5 - Number 47 | December 5, 2007

Subscriber Login
Subscribe to Pharmacogenomics Reporter
Site Licenses
RSS Feed
Archives

In This Week's Issue

CaBIG Users and Developers Meet and Swap Tool-Building Experiences as Network Grows

Compendia to Expand Oncomine with New Meta-Analysis Tool Used to ID Biomarker

Roadrunner Breaks Petaflop Barrier to Crown Top500; Life Science Systems Stable at Four

NSF Bioinformatics Grants Awarded May 29 — June 26, 2008

Sophic, Biomax, University of Texas at Austin, Geospiza, Illumina, Golden Helix, Imperial College London, University of Edinburgh, the University of Alabama at Birmingham, the University Hospital of Schleswig-Holstein in Kiel, Germany, the Hospital for Sick Children in Toronto, GeneGo, VTT of Finland, Progeniq, Univeristy of North Carolina, EPA, Tibco

GenePattern, DNA Analytics 4.0, SynaWorks, CELS@Home

Richard Karp, Alexander Tropsha

Note to Subscribers

Features

Will HPCGG�s New Algorithm Spur Market Adoption of PGx-Based Warfarin Dosing?
HPCGG and the FDA are working together to perfect a dosing algorithm for PGx-guided warfarin dosing with hopes of easing payor and physician reluctance to adopt genetics-based dosing decisions in mainstream practice.

Lilly Official Proclaims Company �On Board� With Personalized Medicine
While critics of personalized medicine complain that it will segment populations and decrease market shares for big pharma’s cash cow drugs, “market segmentation has really been the norm” at Eli Lilly, according to a company official.

PCAST Plans Draft Personalized Medicine Report for Spring; Reimbursement Key Issue
Having heard input from stakeholders for the report, a member of the President’s Council of Advisors on Science and Technology noted that “some of us are cautiously optimistic that personalized medicine will solve some … healthcare issues” like rising healthcare spending, the lack of efficacy of marketed drugs, and the management of drug-induced serious adverse reactions.

Snippets

Delaware Valley Personalized Medicine Project, Aetna, GenoLogics, Molecular Libraries Probe Production Centers Network, Qiagen, University of Miami Genomics Center, FDA, Mayo Clinic, Solgar

Pairings

Ralph Snyderman, Francis Collins, David Sidransky, Michael Liebman